Description:
Scale-up of pharmaceutical unit operations can be challenging as process performance may be scale dependent. The lack of fundamental understanding of the mechanisms governing process performance can lead to broad assumptions during process design, poor identification of critical process parameters, and scale-up complications which are not easily explained. Development of lab scale platforms that serve as scale-down models for pharmaceutical unit operations can provide insights into key mechanisms, streamline process development and drive efficiency. This session seeks papers highlighting innovations in scale-up/scale-down of pharmaceutical unit operations or case studies highlighting common challenges which were overcome by employing particle technology principles.
Sponsor:
Applications of Particle Technology for Pharmaceuticals
Chair:
Preetanshu Pandey
Bristol-Myers Squibb
Pharmaceutical Development
453 Engineering Science Building, PO Box 6102
New Brunswick, NJ
26506
Email: preetanshu.pandey@bms.com
Bristol-Myers Squibb
Pharmaceutical Development
453 Engineering Science Building, PO Box 6102
New Brunswick, NJ
26506
Email: preetanshu.pandey@bms.com
Co-Chair:
Julianna Magnus
Merck and Co.
Pharmaceutical Commercialization Technology
West Point, PA
Email: julianna.magnus@merck.com
Merck and Co.
Pharmaceutical Commercialization Technology
West Point, PA
Email: julianna.magnus@merck.com
Papers:
Abstract Submissions Closed
See more of this Group/Topical: Applications of Particle Technology for Pharmaceuticals
